FEATURES OF THE SECOND HALF OF PREGNANCY IN WOMEN OF REPRODUCTIVE AGE AFTER DIFFERENT METHODS OF TREATMENT OF UTERINE LEIOMYOMA

Authors

  • O. V. Shevchuk Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Sciences of Ukraine, Kyiv https://orcid.org/0000-0002-0936-2759
  • A. E. Dubchak Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Sciences of Ukraine, Kyiv https://orcid.org/0000-0002-6643-7200
  • A. G. Kornatska Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Sciences of Ukraine, Kyiv https://orcid.org/0000-0001-6638-6426
  • O. O. Revenko Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Sciences of Ukraine, Kyiv https://orcid.org/0000-0002-5784-3477

DOI:

https://doi.org/10.11603/24116-4944.2023.2.14387

Keywords:

pregnancy, uterine leiomyoma, conservative myomectomy, pregnant women of reproductive age

Abstract

The aim of the study – to investigate the features of the second half of pregnancy in women after various methods of treatment of uterine leiomyoma.

Materials and Methods. 300 pregnant women in the 2nd and 3rd trimester of pregnancy were examined. Among them – 219 with uterine leiomyoma, (group 1, main group). 114 pregnant women underwent conservative treatment of UL, (group 1a) before pregnancy. 105 pregnant women underwent conservative myomectomy before pregnancy. Of them, 59 women were after laparoscopic myomectomy of the subserosal node or hysteroscopic myomectomy of the submucosal node with coagulation of the bed (group 1 b) and 46 pregnant women – after laparotomy myomectomy with suturing of the bed of the node with vicryl sutures (group 1c). Control group 2 consisted of 81 pregnant women without leiomyoma.

Results and Discussion. The conducted studies indicate that the most frequent complication of pregnancy in the 2–3 trimester in women with UL was the threat of premature birth at 22–27 weeks (47.0 %), (OR: 2.897; 95% CI: 1.625–5.167), and the threat of miscarriage at 12–21.6 weeks (37.4 %), (OR: 3.809; 95% CI: 1.906–7.610). Moreover, in pregnant women with conservative treatment of UL, these complications were almost twice as frequent as in pregnant women after conservative myomectomy (p<0.05). Preeclampsia was present in 29.7 % of patients in the main group, in 6.2 % of the control group (OR 6.416; 95 % CI: 2.481–16.592). Gestation almost did not differ in pregnant women depending on the treatment of leiomyoma before pregnancy. Placental dysfunction was present in 27.9% of pregnant women in the main group versus 7.4 % in controls (OR 4.826; 95 % CI: 1.997–11.664).

Conclusions. In pregnant women with UL in the 2nd and 3rd trimesters of pregnancy, the threat of premature birth and the threat of miscarriage are more common, and these complications prevail in women with conservative treatment of UL compared to patients after conservative myomectomy, which indicates the need for surgical treatment in women with uterine leiomyoma in the pregravid stage stage.

Author Biographies

O. V. Shevchuk, Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Sciences of Ukraine, Kyiv

senior researcher of the department of purulent-inflammation complications of pregnancy of the SI "Institute of Pediatrics, Obstetrics and Gynecology named after acad. O.M. Lukyanova of NAMS of Ukraine"

A. E. Dubchak, Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Sciences of Ukraine, Kyiv

the leading scientific specialist in the rehabilitation of the reproductive function of women of the SI «Institution of Pediatrics, Obstetrics and Gynecology named after acad. O.M. Lukyanova of NAMS of Ukraine"

A. G. Kornatska, Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Sciences of Ukraine, Kyiv

Head of the department of rehabilitation of the reproductive function of women of the SI «Institution of Pediatrics, Obstetrics and Gynecology named after acad. O.M. Lukyanova of NAMS of Ukraine"

O. O. Revenko, Institute of Pediatrics, Obstetrics and Gynecology named after Academician O.M. Lukyanova of the National Academy of Sciences of Ukraine, Kyiv

senior researcher of the Department of Rehabilitation of Women's Reproductive Function of the State University "Institute of Pediatrics, Obstetrics and Gynecology named after Acad. OHM. Lukyanova National Academy of Sciences of Ukraine"

References

Zaporozhan, V.M. (Ed.). Akusherstvo ta hinekolohiia (2014): U 4 t: natsionalnyi pidruchnyk. T.3: Neoperatyvna hinekolohiia [Obstetrics and gynecology: national textbook: in 4 volumes. Vol. 3: Non-operative gynecology]. Kyiv: VSV "Medytsyna". ISBN 978-617-505-257-0. ISBN 978-617-505-297-6 (t.3) [in Ukrainian].

Commandeur, A.Е. (2015). Epidemiological and genetic for molecular mechanismus involved in uterine leiomyoma development and growth. Human Reproduction Update, 21 (5), 593-615. DOI: https://doi.org/10.1093/humupd/dmv030

Sparic, R., & Mirkovic, L. (2016). Epidemiology of uterine myomas: a review. International Journal of Fertility & Sterility, 9 (4), 424-435.

Biglia, N., Carinelii, S., & Maiorana A. (2014). Ulipristal acetate: a novei pharmacological approach for the treatment of uterine fibroids. Drug Design, Development and Therapy, 8, 285-92. DOI: https://doi.org/10.2147/DDDT.S54565

Tafi, E., Scala, C., & Leone, U. (2015) Drug safety evaluation of ulippristal acetate in the treatment of uterine fibroids. Expert Opinion on Drug Safety, 14 (6), 965-77. DOI: https://doi.org/10.1517/14740338.2015.1021773

Tatarchuk, T.F., & Kosei, N.V., Antypkin, Yu.H. (Ed.). (2023). Mioma matky v kn. Akademichni lektsii z akusherstva ta hinekolohii. [Myoma of the uterus 2-nd ed. Academic lectures on obstetrics and gynecology]. Kyiv. TOV "KRIEITIV MEDIA" [in Ukrainian].

Borahay, M., Al-Hendy, A., & Kilic, G. (2015). Signa­ling pathways in leiomyoma: understanding pathobiology and implications for therapy. Molecular Medicine, 21 (1), 242-256. DOI: https://doi.org/10.2119/molmed.2014.00053

Metwally, M., Farquhar, C.M., & Li, T.C. (2011). Is another meta-analysis on the effects f of intramural fibroids on reproductive outcomes needed? Reprod. biomed online, 23 (1), 2-14. DOI: 10.1g16/J.Rbmo.2010.08.006. epub 2010 Sep 6. DOI: https://doi.org/10.1016/j.rbmo.2010.08.006

Parazzini, F., Gerli, S., Bianchi, S., Chiaffarino, F., & Favilli, A. (2021). Global Library of Women's Medicine, ISSM: 1756-2228. DOI: 10.3843/GLOWM415733

Zhang, K., Wiener H., & Aissani, B. (2015). Admixture mapping of genetic variants for uterine fibroids. Journal of Human Genetics, 60, 533-38. DOI: https://doi.org/10.1038/jhg.2015.60

Coronado, G.D., Marshall, L.M., & Schwartz, S.M. (2000). Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet. Gynecol., 95, 764-769. [PUBMED: 10775744]. DOI: https://doi.org/10.1097/00006250-200005000-00025

Perez-roncero, G.R., Lopez-baena, M.T., & Ornat, L. et al. (2020). Uterine fibroids and preterm birth risk: a systematic review and meta-analysis [published online ahead of prinț, 2020 Jul 6]. J. Obstet. Gynaecol. Res., 10.1111/JOG.14343. DOI:10.1111/JOG.14343. DOI: https://doi.org/10.1111/jog.14343

Jenabi, E., & Ebrahimzadeh Zagami, S. (2017). The association between uterine leiomyoma and placenta abruption: a meta-analysis. J. Matern. Fetal. Neonatal. Med., 30 (22), 2742-2746. DOI: 10.1080/14767058.2016.12614019. DOI: https://doi.org/10.1080/14767058.2016.1261401

Published

2024-01-03

How to Cite

Shevchuk, O. V., Dubchak, A. E., Kornatska, A. G., & Revenko, O. O. (2024). FEATURES OF THE SECOND HALF OF PREGNANCY IN WOMEN OF REPRODUCTIVE AGE AFTER DIFFERENT METHODS OF TREATMENT OF UTERINE LEIOMYOMA. Actual Problems of Pediatrics, Obstetrics and Gynecology, (2), 123–128. https://doi.org/10.11603/24116-4944.2023.2.14387

Issue

Section

OBSTETRICS AND GYNECOLOGY